Drugs / human rabies immune globulin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00656097 Comparator | Mar → Jul 2008 | rabies | Crucell Holland BV | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human rabies immune globulin | “The aim of this study is to evaluate the safety of the monoclonal antibody cocktail CL184 in combination with rabies vaccine compared with human rabies immune globulin (HRIG)...” NCT00656097 ↗ |
| Known as | HRIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00656097 ↗ |
| Route | Intramuscular | “HRIG 20 IU/kg intramuscularly on Day0” NCT00656097 ↗ |